Other studies have associated overexpression of PTTG1 and genetic instability in colorectal cancer (Kim et al., 2007), and it has been used as a prognostic marker in skin cancer (Ishitsuka et al., 2013) and breast cancer (Talvinen et al., 2008). This evidence concerns the gene PTTG1 and breast carcinoma.